Belotero Balance®

DEVICE2 trials

Sponsors

Allergan, Merz North America, Inc.

Conditions

Correction of Volume Loss in the Infraorbital Hollow AreaPatients With Moderate to Severe Perioral Lines

Unknown Phase

JUVEDERM® Ultra XC vs. Belotero Balance® for Perioral Lines

CompletedNCT01970397

AllerganPatients With Moderate to Severe Perioral Lines

Start: 2013-10-21End: 2014-08-04Updated: 2019-04-16

A Pilot Study to Assess the Effectiveness and Safety of Belotero Balance® Injection for Volume Augmentation of the Infraorbital Hollow

CompletedNCT03777917

Merz North America, Inc.Correction of Volume Loss in the Infraorbital Hollow Area

Start: 2018-12-27End: 2020-03-11Updated: 2023-11-14